The impact of clinical factors on the development of late radiation toxicity: results from the Medical Research Council RT01 trial (ISRCTN47772397).
Affiliation
University of Cambridge, Department of Oncology, Oncology Centre, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.Issue Date
2011-11
Metadata
Show full item recordAbstract
A variety of dosimetric parameters have been shown to influence the incidence of late radiation toxicity. The effect of other treatment- and patient-related factors is less well established. The aim of this study was to elucidate the influence of such factors in the development of late symptoms after radical radiotherapy to the prostate.Citation
The impact of clinical factors on the development of late radiation toxicity: results from the Medical Research Council RT01 trial (ISRCTN47772397). 2011, 23 (9):613-24 Clin Oncol (R Coll Radiol)Journal
Clinical OncologyDOI
10.1016/j.clon.2011.03.001PubMed ID
21470834Type
ArticleLanguage
enISSN
1433-2981ae974a485f413a2113503eed53cd6c53
10.1016/j.clon.2011.03.001
Scopus Count
Related articles
- Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01 trial (ISRCTN47772397).
- Authors: Syndikus I, Morgan RC, Sydes MR, Graham JD, Dearnaley DP, MRC RT01 collaborators
- Issue date: 2010 Jul 1
- The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397).
- Authors: Dearnaley DP, Sydes MR, Langley RE, Graham JD, Huddart RA, Syndikus I, Matthews JH, Scrase CD, Jose CC, Logue J, Stephens RJ, RT01 Collaborators
- Issue date: 2007 Apr
- Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
- Authors: Michalski JM, Purdy JA, Winter K, Roach M 3rd, Vijayakumar S, Sandler HM, Markoe AM, Ritter MA, Russell KJ, Sailer S, Harms WB, Perez CA, Wilder RB, Hanks GE, Cox JD
- Issue date: 2000 Jan 15
- Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects.
- Authors: Dearnaley DP, Hall E, Lawrence D, Huddart RA, Eeles R, Nutting CM, Gadd J, Warrington A, Bidmead M, Horwich A
- Issue date: 2005 Feb 14
- Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial.
- Authors: Michalski JM, Yan Y, Watkins-Bruner D, Bosch WR, Winter K, Galvin JM, Bahary JP, Morton GC, Parliament MB, Sandler HM
- Issue date: 2013 Dec 1